Home › Funds › Ikarian Capital, LLC › ALEC
Ikarian Capital, LLC position in ALEC
ALECTOR INC COM · Health Care
Ikarian Capital, LLC reported holding 1,982,606 shares of ALEC (ALECTOR INC COM) in its Q2 2026 13F filing — a position valued at US$4.0M, representing 0.64% of its reported portfolio and ranking #50 among its reported holdings. Ikarian Capital, LLC has disclosed ALEC holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ikarian Capital, LLC's ALEC position evolved
Ikarian Capital, LLC first disclosed a stake in ALEC in Q4 2024 at 950,000 shares (US$1.8M). The position peaked in Q1 2026 at 2,082,606 shares, worth US$4.5M. Across 7 filings, Ikarian Capital, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 1,982,606 shares valued at US$4.0M — a reduction of -100,000 shares quarter over quarter.. Notable position changes include a 174% increase in Q4 2025 (shares rose 38% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 950.00K | $1.80M | New |
| Q1 2025 | 950.00K | $1.17M | Hold |
| Q2 2025 | 900.00K | $1.26M | Reduce |
| Q3 2025 | 760.00K | $2.25M | Reduce |
| Q4 2025 | 2.08M | $3.25M | Add |
| Q1 2026 | 2.08M | $4.48M | Hold |
| Q2 2026 | 1.98M | $3.99M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALEC and 13F data
ALEC (ALECTOR INC COM) is a Health Care company. 30 other funds we track also report a position in ALEC — the largest reported positions include TCG Crossover Management, LLC (US$20.1M), Kynam Capital Management, LP (US$7.7M), Merck & Co., Inc. (US$7.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALEC
- TCG Crossover Management, LLC 10.00M sh · $20.10M · Q2 2026
- Kynam Capital Management, LP 3.81M sh · $7.66M · Q2 2026
- Merck & Co., Inc. 3.55M sh · $7.13M · Q2 2026
- Spruce Street Capital LP 2.10M sh · $4.22M · Q2 2026
- MEDICI CAPITAL LLC 1.65M sh · $3.32M · Q2 2026
- Euclidean Capital LLC 1.31M sh · $2.63M · Q2 2026
More on Ikarian Capital, LLC
FAQ
How long has Ikarian Capital, LLC held ALEC?
Ikarian Capital, LLC has disclosed ALEC holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Ikarian Capital, LLC's current position in ALEC?
As of Q2 2026, Ikarian Capital, LLC holds 1.98M shares of ALEC (ALECTOR INC COM), valued at $3.99M, representing 0.64% of its reported portfolio and ranking #50.
Has Ikarian Capital, LLC been buying or selling ALEC?
In the latest 13F filing (Q2 2026), Ikarian Capital, LLC reduced its position in ALEC. The position peaked in Q1 2026 at 2.08M shares.
Which other funds hold ALEC?
Other major institutional holders of ALEC include TCG Crossover Management, LLC, Kynam Capital Management, LP, Merck & Co., Inc., among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.